middle.news
Proteomics International Advances Commercial Pivot with Revenue Growth
4:35pm on Monday 31st of August, 2026 AEST
•
Healthcare
Read Story
Proteomics International Advances Commercial Pivot with Revenue Growth
4:35pm on Monday 31st of August, 2026 AEST
Key Points
3% revenue increase to AUD 3.61 million
Net loss widened 5.5% to AUD 8.56 million
Strategic shift away from direct-to-consumer model
Exclusive three-year distribution deal with Healius
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Proteomics International Laboratories (ASX:PIQ)
OPEN ARTICLE